Harmone Receptor-positive, HER2-negative Early Breast Cancer Adjuvant Use of Abemaciclib nearly halves the Incidence of Distant Metastases

被引：0
|
作者：
Ruedesheim, Sabine M.
机构：
来源：
ONCOLOGY RESEARCH AND TREATMENT | 2023年 / 46卷 / 06期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页数：1
相关论文
共 50 条
  • [31] A Multicenter, Phase Ib/II Study of Abemaciclib in Combination with Bicalutamide for Androgen Receptor-positive, HER2-negative Metastatic Breast Cancer
    Casasanta, Nicole
    Landry, Chrystal
    Shao, Theresa
    Klein, Paula
    Fasano, Julie
    Bhardwaj, Aarti
    Berger, Natalie
    Moshier, Erin
    Joshi, Gargi Atul
    Vaccaro, Rita
    Sparano, Joseph
    Tiersten, Amy
    CANCER RESEARCH, 2024, 84 (09)
  • [32] Benefit of adjuvant chemotherapy in hormone receptor-positive, HER2-negative, invasive lobular carcinoma of the breast
    De Nonneville, A.
    Jauffret, C.
    Goncalves, A.
    Classe, J-M.
    Cohen, M.
    Reyal, F.
    Mazouni, C.
    Chauvet, M-P.
    Chopin, N.
    Colombo, P-E.
    Jouve, E.
    Darai, E.
    Rouzier, R.
    Coutant, C.
    Gimbergues, P.
    Azuar, A-S.
    de Lara, C. Tunon
    Lambaudie, E.
    Houvenaeghel, G.
    ANNALS OF ONCOLOGY, 2018, 29 : 62 - 62
  • [33] A look at current and potential treatment approaches for hormone receptor-positive, HER2-negative early breast cancer
    Harbeck, Nadia
    Burstein, Harold J.
    Hurvitz, Sara A.
    Johnston, Stephen
    Vidal, Gregory A.
    CANCER, 2022, 128 : 2209 - 2223
  • [34] Neoadjuvant chemotherapy in hormone receptor-positive/HER2-negative early breast cancer: When, why and what?
    Torrisi, Rosalba
    Marrazzo, Emilia
    Agostinetto, Elisa
    De Sanctis, Rita
    Losurdo, Agnese
    Masci, Giovanna
    Tinterri, Corrado
    Santoro, Armando
    CRITICAL REVIEWS IN ONCOLOGY HEMATOLOGY, 2021, 160
  • [35] T5 Is a New Molecular Predictor of Distant Recurrence in Estrogen Receptor-Positive, HER2-Negative Breast Cancer
    Filipits, M.
    Rudas, M.
    Jakesz, R.
    Dubsky, P.
    Singer, C. F.
    Dietze, O.
    Greil, R.
    Jelen, A.
    Sevelda, P.
    Freibauer, C.
    Fitzal, F.
    Mueller, V.
    Jaenicke, F.
    Schmidt, M.
    Koelbl, H.
    Rody, A.
    Kaufmann, M.
    Schroth, W.
    Schwab, M.
    Brauch, H.
    Weber, K.
    Feder, I.
    Hennig, G.
    Gehrmann, M.
    Gnant, M. F. X.
    CANCER RESEARCH, 2010, 70
  • [36] Abemaciclib in Combination with Endocrine Therapy for Adjuvant Treatment of Hormone Receptor-Positive, HER2-Negative, Node-Positive Early Breast Cancer: An Evidence Review Group Perspective of a NICE Single Technology Appraisal
    Giovany Orozco Leal
    Nigel Armstrong
    Ashleigh Kernohan
    Charlotte Ahmadu
    Diarmuid Coughlan
    Kevin McDermott
    Steven Duffy
    Susan O’Meara
    Tomos Robinson
    Luke Vale
    Jos Kleijnen
    PharmacoEconomics, 2023, 41 : 741 - 750
  • [37] Abemaciclib in Combination with Endocrine Therapy for Adjuvant Treatment of Hormone Receptor-Positive, HER2-Negative, Node-Positive Early Breast Cancer: An Evidence Review Group Perspective of a NICE Single Technology Appraisal
    Orozco Leal, Giovany
    Armstrong, Nigel
    Kernohan, Ashleigh
    Ahmadu, Charlotte
    Coughlan, Diarmuid
    McDermott, Kevin
    Duffy, Steven
    O'Meara, Susan
    Robinson, Tomos
    Vale, Luke
    Kleijnen, Jos
    PHARMACOECONOMICS, 2023, 41 (07) : 741 - 750
  • [38] The natural history of untreated estrogen receptor-positive, Her2-negative invasive breast cancer
    Kristin E. Rojas
    Donna-Marie Manasseh
    Mary Rojas
    Andrea Mattocks
    Leah Portnow
    Sarah Kantharia
    Natalie Zelenko
    Christina Giuliano
    Patrick I. Borgen
    Breast Cancer Research and Treatment, 2020, 182 : 79 - 83
  • [39] Current Landscape of Targeted Therapy in Hormone Receptor-Positive and HER2-Negative Breast Cancer
    Andrahennadi, Samitha
    Sami, Amer
    Manna, Mita
    Pauls, Mehrnoosh
    Ahmed, Shahid
    CURRENT ONCOLOGY, 2021, 28 (03) : 1803 - 1822
  • [40] Spatial interplay of lymphocytes and fibroblasts in estrogen receptor-positive HER2-negative breast cancer
    Nederlof, I
    Hajizadeh, S.
    Sobhani, F.
    Raza, S. E. A.
    AbdulJabbar, K.
    Harkes, R.
    van de Vijver, M. J.
    Salgado, R.
    Desmedt, C.
    Kok, M.
    Yuan, Y.
    Horlings, H. M.
    NPJ BREAST CANCER, 2022, 8 (01)
12345